LONG-ACTING LENACAPAVIR in PEOPLE with MULTIDRUG RESISTANT HIV-1: WEEK 52 RESULTS

Category Primary study
JournalTopics in Antiviral Medicine
Year 2022
This article has no abstract
Epistemonikos ID: 08cf0f23c36523657318b846feaba348277dd964
First added on: Feb 14, 2025